Jonathan D Schertzer Selected Research

Jonathan D Schertzer Research Topics

Disease

32	Inflammation (Inflammations) 01/2022 - 01/2009
32	Insulin Resistance 01/2022 - 01/2009
23	Obesity 01/2022 - 11/2010
9	Type 2 Diabetes Mellitus (MODY) 01/2021 - 12/2011
6	Metabolic Diseases (Metabolic Disease) 05/2021 - 12/2015
5	Neoplasms (Cancer) 01/2022 - 04/2005
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 04/2014
5	Muscular Dystrophies (Muscular Dystrophy) 04/2012 - 01/2007
4	Glucose Intolerance 01/2022 - 01/2013
4	Hypertrophy 12/2018 - 04/2006
4	Muscular Diseases (Myopathy) 01/2016 - 04/2006
3	Non-alcoholic Fatty Liver Disease 01/2022 - 12/2013
3	Hyperinsulinism (Hyperinsulinemia) 12/2020 - 01/2013
3	Heart Failure 01/2020 - 03/2007
3	Fatigue 04/2017 - 09/2006
3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 04/2012 - 04/2005
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 10/2018
2	Endotoxemia 01/2021 - 05/2017
2	Infections 01/2020 - 01/2016
2	Hyperglycemia 12/2018 - 10/2018
2	Dysbiosis 05/2017 - 03/2015
2	Sarcopenia 01/2017 - 08/2007
2	Cachexia 03/2007 - 04/2005
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Weight Gain 01/2022
1	Crohn Disease (Crohn's Disease) 01/2021
1	Hyperphagia (Overeating) 01/2020
1	Morbid Obesity 01/2020
1	Atherosclerotic Plaque (Atheroma) 01/2020

Drug/Important Bio-Agent (IBA)

20	Insulin (Novolin)FDA Link 01/2022 - 01/2009
15	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2009
12	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2010
9	NucleotidesIBA 01/2022 - 12/2010
8	InflammasomesIBA 01/2020 - 04/2014
7	Blood Glucose (Blood Sugar)IBA 01/2021 - 01/2017
7	LipidsIBA 01/2021 - 09/2011
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 11/2014
6	Peptidoglycan (Murein)IBA 01/2019 - 09/2011
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 10/2009
5	CytokinesIBA 12/2018 - 04/2005
4	Phosphotransferases (Kinase)IBA 01/2021 - 01/2009
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 05/2017
4	LigandsIBA 01/2020 - 12/2010
4	CholesterolIBA 01/2020 - 10/2015
4	Insulin-Like Growth Factor I (IGF-1)IBA 11/2008 - 04/2006
3	Pharmaceutical PreparationsIBA 01/2022 - 12/2013
3	LipopolysaccharidesIBA 01/2021 - 05/2017
3	AMP-Activated Protein KinasesIBA 01/2020 - 12/2013
3	Fluvastatin FDA Link 01/2017 - 11/2014
3	Pattern Recognition ReceptorsIBA 03/2015 - 12/2010
3	Formoterol Fumarate (Oxis)FDA Link 07/2008 - 01/2007
2	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 12/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 12/2010
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2017
2	Terpenes (Terpenoids)IBA 01/2020 - 01/2019
2	Caspase 1 (ICE Protease)IBA 01/2019 - 11/2014
2	DiglyceridesIBA 01/2019 - 12/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018 - 04/2017
2	ResveratrolIBA 10/2018 - 04/2017
2	Insulin Receptor Substrate ProteinsIBA 01/2013 - 12/2010
2	DystrophinIBA 04/2012 - 01/2008
2	p38 Mitogen-Activated Protein KinasesIBA 12/2010 - 01/2009
2	Anabolic AgentsIBA 01/2007 - 04/2005
1	Volatile Fatty AcidsIBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Butyrates (Butyrate)IBA 01/2022
1	PropionatesIBA 01/2022
1	SterolsIBA 01/2022
1	IronIBA 05/2021
1	Dietary Fiber FDA Link 01/2021
1	AntioxidantsIBA 01/2021
1	Biological ProductsIBA 01/2021
1	EndotoxinsIBA 01/2021
1	Glucagon-Like Peptides (Enteroglucagon)IBA 01/2021
1	Inositol (Myoinositol)IBA 01/2021
1	Lipid AIBA 01/2021
1	Ribonucleases (Ribonuclease)IBA 01/2021
1	Sucrose (Saccharose)IBA 01/2021
1	Taurochenodeoxycholic AcidIBA 01/2021
1	Thyroid HormonesIBA 01/2021
1	Trace Elements (Biometals)IBA 01/2021
1	VitaminsIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2021
1	MicronutrientsIBA 01/2021
1	Sirtuin 1IBA 01/2021
1	MTOR InhibitorsIBA 01/2020
1	Sodium-Glucose Transport ProteinsIBA 01/2020
1	Apolipoproteins E (ApoE)IBA 01/2020
1	KetonesIBA 01/2020
1	AdipokinesIBA 01/2020
1	CanagliflozinIBA 01/2020
1	Receptor-Interacting Protein Serine-Threonine Kinase 2 (CARDIAK)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	LDL CholesterolIBA 01/2019

Therapy/Procedure

7	Glycemic Control 01/2022 - 12/2015
6	Therapeutics 01/2017 - 11/2008
1	Immunotherapy 01/2021
1	Caloric Restriction 01/2020